vs

Side-by-side financial comparison of Jefferson Capital, Inc. (JCAP) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Jefferson Capital, Inc. is the larger business by last-quarter revenue ($150.8M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp). Jefferson Capital, Inc. runs the higher net margin — 25.4% vs -38.1%, a 63.5% gap on every dollar of revenue.

GE Capital was the financial services division of General Electric. Its various units were sold between 2013 and 2021, including the notable spin-off of the North American consumer finance division as Synchrony Financial. Ultimately, only one division of the company remained, GE Energy Financial Services, which was transferred to GE Vernova when General Electric was broken up.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

JCAP vs PRCT — Head-to-Head

Bigger by revenue
JCAP
JCAP
1.8× larger
JCAP
$150.8M
$83.1M
PRCT
Higher net margin
JCAP
JCAP
63.5% more per $
JCAP
25.4%
-38.1%
PRCT

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
JCAP
JCAP
PRCT
PRCT
Revenue
$150.8M
$83.1M
Net Profit
$38.4M
$-31.6M
Gross Margin
64.9%
Operating Margin
46.4%
-4.1%
Net Margin
25.4%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.59
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JCAP
JCAP
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$150.8M
$83.3M
Q2 25
$152.7M
$79.2M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$53.4M
Net Profit
JCAP
JCAP
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$38.4M
$-21.4M
Q2 25
$47.7M
$-19.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$-25.6M
Gross Margin
JCAP
JCAP
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
JCAP
JCAP
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
46.4%
-27.8%
Q2 25
56.7%
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
JCAP
JCAP
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
25.4%
-25.7%
Q2 25
31.2%
-24.7%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
-48.0%
EPS (diluted)
JCAP
JCAP
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$0.59
$-0.38
Q2 25
$16.76
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JCAP
JCAP
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$42.3M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$437.4M
$347.7M
Total Assets
$1.8B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JCAP
JCAP
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$42.3M
$294.3M
Q2 25
$51.7M
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
JCAP
JCAP
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
JCAP
JCAP
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$437.4M
$380.3M
Q2 25
$410.8M
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Total Assets
JCAP
JCAP
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$1.8B
$511.5M
Q2 25
$1.8B
$513.1M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$374.4M
Debt / Equity
JCAP
JCAP
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JCAP
JCAP
PRCT
PRCT
Operating Cash FlowLast quarter
$63.1M
Free Cash FlowOCF − Capex
$63.0M
FCF MarginFCF / Revenue
41.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JCAP
JCAP
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$63.1M
$-6.6M
Q2 25
$130.6M
$-15.0M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
JCAP
JCAP
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$63.0M
$-9.5M
Q2 25
$130.0M
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
JCAP
JCAP
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
41.7%
-11.4%
Q2 25
85.1%
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
JCAP
JCAP
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
0.1%
3.4%
Q2 25
0.4%
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
JCAP
JCAP
PRCT
PRCT
Q1 26
Q4 25
Q3 25
1.64×
Q2 25
2.74×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JCAP
JCAP

United States Segment$108.1M72%
Other$35.8M24%
United Kingdom Segment$6.9M5%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons